| 1 |
Temporal development of neurochemical and cognitive impairments following reserpine administration in rats |
|
|
| Aline Guimarães Pereira, Anicleto Poli, Filipe Carvalho Matheus, Lucila de Bortoli da Silva, Guilherme Pasetto Fadanni, Geison Souza Izídio, Alexandra Latini, Rui Daniel Prediger |
|
| Behavioural Brain Research. 2020; 383: 112517 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Post-Treatment with Erinacine A, a Derived Diterpenoid of H. erinaceus, Attenuates Neurotoxicity in MPTP Model of Parkinson’s Disease |
|
|
| Kam-Fai Lee, Shui-Yi Tung, Chih-Chuan Teng, Chien-Heng Shen, Meng Chiao Hsieh, Cheng-Yi Huang, Ko-Chao Lee, Li-Ya Lee, Wan-Ping Chen, Chin-Chu Chen, Wen-Shih Huang, Hsing-Chun Kuo |
|
| Antioxidants. 2020; 9(2): 137 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
N,N,N-trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery |
|
|
| Chandrakantsing V. Pardeshi, Veena S. Belgamwar |
|
| International Journal of Biological Macromolecules. 2018; 120: 2560 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease |
|
|
| D.B. Hoban,L. Howard,E. Dowd |
|
| Neuroscience. 2015; 303: 402 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinsonæs disease models |
|
|
| Q. Wang,L. Qian,S.-H. Chen,C.-H. Chu,B. Wilson,E. Oyarzabal,S. Ali,B. Robinson,D. Rao,J.-S. Hong |
|
| Brain. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach |
|
|
| Chandrakantsing V. Pardeshi,Pravin V. Rajput,Veena S. Belgamwar,Avinash R. Tekade,Sanjay J. Surana |
|
| Drug Delivery. 2013; 20(1): 47 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation |
|
|
| Chandrakantsing V. Pardeshi,Veena S. Belgamwar,Avinash R. Tekade,Sanjay J. Surana |
|
| Journal of Materials Science: Materials in Medicine. 2013; 24(9): 2101 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function |
|
|
| O.M. Littrell,J.L. Fuqua,A.D. Richardson,J. Turchan-Cholewo,E.R. Hascup,P. Huettl,F. Pomerleau,L.H. Bradley,D.M. Gash,G.A. Gerhardt |
|
| Neuropeptides. 2013; 47(1): 43 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinsonæs disease |
|
|
| Li Zuo,Michael S. Motherwell |
|
| Gene. 2013; 532(1): 18 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function |
|
|
| Littrell, O.M. and Fuqua, J.L. and Richardson, A.D. and Turchan-Cholewo, J. and Hascup, E.R. and Huettl, P. and Pomerleau, F. and Bradley, L.H. and Gash, D.M. and Gerhardt, G.A. |
|
| Neuropeptides. 2013; 47(1): 43-49 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: Application of factorial design approach |
|
|
| Pardeshi, C.V. and Rajput, P.V. and Belgamwar, V.S. and Tekade, A.R. and Surana, S.J. |
|
| Drug Delivery. 2013; 20(1): 47-56 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Mifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo |
|
|
| Wang, Y., Yang, D., Song, L., Li, T., Yang, J., Zhang, X., Le, W. |
|
| Stem Cells. 2012; 30(2): 169-179 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Mifepristone-Inducible Caspase-1 Expression in Mouse Embryonic Stem Cells Eliminates Tumor Formation but Spares Differentiated Cells In Vitro and In Vivo |
|
|
| Yi Wang,Dehua Yang,Lin Song,Ting Li,Juan Yang,Xiaojie Zhang,Weidong Le |
|
| STEM CELLS. 2012; 30(2): 169 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Mitochondrial therapeutics in Alzheimeræs disease and Parkinsonæs disease |
|
|
| Hoekstra, J.G. and Montine, K.S. and Zhang, J. and Montine, T.J. |
|
| Alzheimeræs Research and Therapy. 2011; 3(3) |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Therapeutic applications of antibodies in non-infectious neurodegenerative diseases |
|
|
| Krishnamurthy, P.K., Sigurdsson, E.M. |
|
| New Biotechnology. 2011; 28(5): 511-517 |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Therapeutic applications of antibodies in non-infectious neurodegenerative diseases |
|
|
| Pavan K. Krishnamurthy,Einar M. Sigurdsson |
|
| New Biotechnology. 2011; 28(5): 511 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
